ERI2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.414800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.299800E-01
Normal-vs-Stage2
6.654800E-01
Normal-vs-Stage3
1.952370E-01
Normal-vs-Stage4
5.280400E-01
Stage1-vs-Stage2
2.737400E-01
Stage1-vs-Stage3
3.712100E-02
Stage1-vs-Stage4
8.786000E-01
Stage2-vs-Stage3
5.87008219810059E-12
Stage2-vs-Stage4
5.931400E-01
Stage3-vs-Stage4
2.021800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.931000E-01
Normal-vs-AfricanAmerican
7.255400E-01
Normal-vs-Asian
3.930400E-01
Caucasian-vs-AfricanAmerican
7.228600E-01
Caucasian-vs-Asian
1.802830E-01
AfricanAmerican-vs-Asian
9.320400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.061600E-01
Normal-vs-Female
6.790800E-01
Male-vs-Female
3.267000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.175000E-01
Normal-vs-Age(41-60Yrs)
7.002200E-01
Normal-vs-Age(61-80Yrs)
7.688800E-01
Normal-vs-Age(81-100Yrs)
7.562200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.937000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.348400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.803000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.895800E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.695400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.177800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.918000E-01
Normal-vs-Daily Drinker
7.796800E-01
Normal-vs-Weekly Drinker
9.144400E-01
Normal-vs-Occasional Drinker
6.200400E-01
Normal-vs-Social Drinker
6.139400E-01
Non Drinker-vs-Daily Drinker
9.517200E-01
Non Drinker-vs-Weekly Drinker
5.768800E-01
Non Drinker-vs-Occasional Drinker
6.823800E-01
Non Drinker-vs-Social Drinker
9.340600E-01
Daily Drinker-vs-Weekly Drinker
6.286400E-01
Daily Drinker-vs-Occasional Drinker
8.061400E-01
Daily Drinker-vs-Social Drinker
9.966400E-01
Weekly Drinker-vs-Occasional Drinker
4.317400E-01
Weekly Drinker-vs-Social Drinker
5.309800E-01
Occasional Drinker-vs-Social Drinker
7.688200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.249400E-01
Normal-vs-Grade 2
8.274300E-02
Normal-vs-Grade 3
4.017900E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.237700E-03
Grade 1-vs-Grade 3
8.846000E-04
Grade 1-vs-Grade 4
2.249400E-01
Grade 2-vs-Grade 3
3.669400E-01
Grade 2-vs-Grade 4
8.274300E-02
Grade 3-vs-Grade 4
4.017900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.116400E-01
Normal-vs-NonDiabetic
7.074800E-01
Diabetic-vs-NonDiabetic
5.956100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.787200E-01
Normal-vs-NoPancreatitis
8.370200E-01
Pancreatitis-vs-NoPancreatitis
1.000760E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.600400E-01
Normal-vs-N1
7.085800E-01
N0-vs-N1
9.036200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.219200E-01
Normal-vs-TP53-NonMutant
6.785400E-01
TP53-Mutant-vs-TP53-NonMutant
3.400100E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
